ReviewFrontiers in medicine2022

Alpha-peptide receptor radionuclide therapy using actinium-225 labeled somatostatin receptor agonists and antagonists.

Mengqi Shi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.